Concepedia

Amber Giles

AG

16

Publications

2.9K

Citations

15

H-Index

2009

Active since

Affiliations

National Cancer Institute(Current)

National Institutes of Health

National Institute of Neurological Disorders and Stroke

Center for Cancer Research

Massachusetts Institute of Technology

Amber Giles is an author at National Cancer Institute specializing in medicine, cell biology, and cell signaling.

ORCID

Top concepts

Publications per year

2009–2021

16

Publications

16

Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy

Steven L. Highfill, Yongzhi Cui, Amber Giles et al. · Science Translational Medicine · 2014 · 742 citations · Full text

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Karolina Woroniecka, Pakawat Chongsathidkiet, Kristen E. Rhodin et al. · Clinical Cancer Research · 2018 · 610 citations

Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy

Amber Giles, Marsha-Kay Hutchinson, Heather M. Sonnemann et al. · Journal for ImmunoTherapy of Cancer · 2018 · 465 citations · Full text

Hepatic overexpression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver

Yu Li, Shanqin Xu, Amber Giles et al. · The FASEB Journal · 2011 · 290 citations

, , +21

Hepatic SIRT1 Attenuates Hepatic Steatosis and Controls Energy Balance in Mice by Inducing Fibroblast Growth Factor 21

Yu Li, Kimberly Wong, Amber Giles et al. · Gastroenterology · 2013 · 282 citations · Full text

, , +11

Rows per page

1–5 of 16